David Shen
Directeur Général chez Proteologix US, Inc.
Postes actifs de David Shen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Proteologix US, Inc.
 Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Directeur Général | - | - |
| Président | - | - | |
| Directeur Financier/CFO | - | - | |
| Secrétaire Général | - | - |
Historique de carrière de David Shen
Anciens postes connus de David Shen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | - | 01/07/2021 |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Corporate Officer/Principal | - | - |
| Merck, Inc. | Corporate Officer/Principal | - | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - | - |
Formation de David Shen
| East China University of Science & Technology | Undergraduate Degree |
| University of Toronto | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Chine | 2 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
| Merck, Inc. | |
GlycoFi, Inc.
GlycoFi, Inc. BiotechnologyHealth Technology GlycoFi, Inc. develops biopharmaceutical products. It provides protein production technology to develop, produce and commercialize biotherapeutics products. The company was founded by Tillman Gerngross in 2000 and is headquartered in Lebanon, NH. | Health Technology |
Proteologix US, Inc.
Proteologix US, Inc. BiotechnologyHealth Technology Proteologix US, Inc. is based in Redwood City, CA. Part of Johnson & Johnson, Proteologix US, Inc. is a biopharmaceutical company. The CEO of the company is David Wenyan Shen. Proteologix US was acquired by Johnson & Johnson on June 21, 2024 for $850 million. | Health Technology |
- Bourse
- Insiders
- David Shen
- Expérience
